ARTICLE | Company News

Endorex deal with Novo Nordisk

March 1, 2000 8:00 AM UTC

Under a research and option agreement, the companies will evaluate oral delivery of NVO's Norditropin human growth hormone in preclinical models. NVO has exclusive rights to license DOR's Orasome oral drug delivery system for Norditropin. ...